載入...
Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by platelet count less than 100×10(9)/L and an increased risk of bleeding. The risk of bleeding increases in proportion with the degree of thrombocytopenia. Although several medications are used for primary thrombocytopenia treatm...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7505620/ https://ncbi.nlm.nih.gov/pubmed/32968581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9920 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|